Lupin Limited Gets 3 Observations After USFDA Inspection of Somerset Facility Parthika Patel20 April 2026 7:00 PM ISTNew Delhi: Lupin Limited has informed that the United States Food and Drug Administration (USFDA) has concluded an inspection at its manufacturing...
Mankind Pharma Founder Shri Ramesh Juneja Honoured with Punjab Ratan Award Medical Dialogues Bureau15 April 2026 3:30 PM ISTNew Delhi: In a moment of recognition for a remarkable journey in Indian pharmaceuticals, Shri Ramesh Juneja, Founder and Chairman of Mankind Pharma,...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Lupin, Zydus Secure USFDA Nod for Dapagliflozin Tablets Parthika Patel9 April 2026 5:50 PM ISTNew Delhi: Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration (USFDA) for...
Lupin Gets USFDA Tentative Approval for Generic Anesthesia Reversal Drug Sugammadex sheeba farhat1 April 2026 4:52 PM ISTMumbai: Global pharma major, Lupin Limited (Lupin) has announced that it has received tentative approval from the United States Food and Drug...
Lupin Gets USFDA Tentative Nod for Generic Pitolisant Tablets for Sleep Disorder sheeba farhat30 March 2026 12:30 PM ISTNew Delhi: Pharma major Lupin Ltd on Wednesday said it has received tentative approval from the US health regulator for its generic version of...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant Kajal Rajput27 Feb 2026 7:08 PM ISTNew Delhi: Drug maker Lupin on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Goa-based...
SC Seeks Centre, DCGI Response on Micro Labs' Plea Against Anti-Diabetic FDC Ban Susmita Roy26 Feb 2026 10:26 PM ISTNew Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro...
Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in US Parthika Patel25 Feb 2026 2:01 PM ISTMumbai: Mumbai-based pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (USFDA) for its Brivaracetam...
Lupin Gets Zero USFDA Observations for Nagpur Plant sheeba farhat15 Feb 2026 11:30 AM ISTMumbai: Lupin Limited has announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its Nagpur...
Lupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India Region Susmita Roy13 Feb 2026 1:21 PM ISTNew Delhi: Lupin has announced the appointment of Dr Kushkumar Thakare as Manager, Medical Affairs, India Region Formulations, reinforcing the...
